+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Modafinil Oral Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140193
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The modafinil oral drugs market is experiencing rapid evolution as senior decision-makers seek reliable solutions for cognitive health management. As advancements in drug delivery and new regulatory environments shape industry strategies, understanding how to navigate these dynamics is essential for sustained business growth.

Market Snapshot: Modafinil Oral Drugs at a Turning Point

The global modafinil oral drugs sector is witnessing robust market activity, characterized by both the proliferation of branded offerings and the rising penetration of generics. A key driver of this market is the drug’s established efficacy in neurological and cognitive disorder management, supported by a favorable safety profile and lower dependency risk relative to traditional stimulants. The market reflects increased adoption of innovative formulation technologies and a dynamic shift in distribution channels, blending in-person and digital pharmacy models. Gradual geographic diversification and supply chain recalibration further underline the market’s resilience amid dynamic regulatory and tariff environments.

Scope & Segmentation: Comprehensive Coverage across the Modafinil Landscape

  • Product Types: Brand and generic modafinil, including prominent brands such as Provigil.
  • Dosage Strengths: 100 mg and 200 mg, supporting tailored therapeutic regimens.
  • Applications: Covers ADHD, cognitive enhancement, narcolepsy, and shift work sleep disorder, reflecting a broad spectrum of patient needs.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies, indicating varied procurement and access pathways.
  • End-Users: Clinics, home care, and hospitals, demonstrating diversified consumption environments.
  • Regional Focus: Americas, Europe, Middle East & Africa, and Asia-Pacific, with sub-regional insights from North America, major European nations, MEA, and key Asia-Pacific markets.
  • Technology Use: Extended-release formulations, multiparticulate matrices, micronized suspensions, and integration of AI tools in clinical trials.

Primary Keyword Focus: Modafinil Oral Drugs Market

The modafinil oral drugs market stands out for its strategic importance as healthcare systems pivot towards cognitive enhancement and personalized therapies. Pharmaceutical executives should note how emerging technologies and product innovations are unlocking more precise control of therapeutic effects and offering enhanced patient compliance.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Modafinil’s clinical profile now supports a spectrum of neurological conditions, leading to expanded indications beyond its original use.
  • Innovations in extended-release and targeted delivery systems are improving patient adherence and differentiating products in competitive environments.
  • Combination therapies pairing modafinil with adjunct neuroprotective agents signal a broader industry move toward precision medicine and patient stratification.
  • Tariff changes in the U.S. are prompting companies to diversify sourcing and enhance supply chain resilience by shifting procurement to regions with favorable trade policies.
  • Regional dynamics drive strategic opportunities, with the Americas leveraging research infrastructure and Asia-Pacific experiencing growth through digital health platforms and distribution partnerships.

Tariff Impact: Supply Chain Adaptation in Response to U.S. Policy

Recent U.S. tariff adjustments on pharmaceutical precursors are reshaping the global modafinil supply chain. Elevated duties on key inputs have triggered geographic diversification in raw material sourcing and catalyzed new trade negotiations aimed at supply continuity. Downstream, companies are consolidating logistics and streamlining warehousing to control costs and maintain market accessibility.

Methodology & Data Sources

This report is built on a robust research process, with primary insights obtained from interviews with industry leaders, clinical authorities, and supply chain professionals. Extensive secondary research involved peer-reviewed studies, regulatory data, trade associations, and market surveys. Advanced analytics and scenario-based models underpin the rigor and reliability of the presented findings.

Why This Report Matters

  • Empowers decision-makers to identify growth opportunities through actionable segmentation and technology roadmaps.
  • Delivers forward-looking perspectives into regulatory shifts, market innovations, and evolving patient needs.
  • Supports strategic planning with insights into supply chain resilience, partnerships, and adaptation to regional market drivers.

Conclusion

The modafinil oral drugs market is poised for continued transformation, presenting new pathways for value creation and operational excellence. Stakeholders who leverage timely insights and adapt to emerging trends will be best positioned for long-term success in this evolving therapeutic arena.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding research on novel modafinil analogues designed to improve cognitive benefits with fewer side effects
5.2. Growing partnerships between pharmaceutical companies and academic institutions for modafinil drug delivery innovations
5.3. Increasing adoption of telemedicine platforms for remote prescribing and monitoring of modafinil therapy among patients
5.4. Emergence of digital adherence monitoring tools and mobile apps to track patient compliance with modafinil regimens
5.5. Heightened regulatory scrutiny on modafinil distribution and labeling guidelines to curb off-label misuse and diversion
5.6. Expansion of generic modafinil production capacities driven by patent expirations and cost containment priorities in healthcare
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Modafinil Oral Drugs Market, by Product Type
8.1. Introduction
8.2. Brand
8.2.1. Provigil
8.3. Generic
9. Modafinil Oral Drugs Market, by Dosage Strength
9.1. Introduction
9.2. 100 Mg
9.3. 200 Mg
10. Modafinil Oral Drugs Market, by Application
10.1. Introduction
10.2. Adhd
10.3. Cognitive Enhancement
10.4. Narcolepsy
10.5. Shift Work Sleep Disorder
11. Modafinil Oral Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Modafinil Oral Drugs Market, by End-User
12.1. Introduction
12.2. Clinics
12.3. Home Care
12.4. Hospitals
13. Americas Modafinil Oral Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Modafinil Oral Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Modafinil Oral Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sun Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Glenmark Pharmaceuticals Ltd.
16.3.5. Intas Pharmaceuticals Ltd.
16.3.6. Dr. Reddy's Laboratories Ltd.
16.3.7. Aurobindo Pharma Ltd.
16.3.8. Cipla Ltd.
16.3.9. Hetero Healthcare Ltd.
16.3.10. Lupin Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MODAFINIL ORAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MODAFINIL ORAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MODAFINIL ORAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MODAFINIL ORAL DRUGS MARKET: RESEARCHAI
FIGURE 26. MODAFINIL ORAL DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. MODAFINIL ORAL DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. MODAFINIL ORAL DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MODAFINIL ORAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PROVIGIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY PROVIGIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY 100 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY 200 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY ADHD, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY ADHD, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY COGNITIVE ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY NARCOLEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY SHIFT WORK SLEEP DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY SHIFT WORK SLEEP DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MODAFINIL ORAL DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MODAFINIL ORAL DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 79. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 82. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 83. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 84. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 85. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. CANADA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 94. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 95. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 96. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 97. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 102. MEXICO MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 144. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 153. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 156. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 157. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 158. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 159. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. GERMANY MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 168. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 169. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 176. FRANCE MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 177. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 180. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 189. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 192. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 193. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 200. ITALY MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 201. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 204. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 205. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 212. SPAIN MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 228. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 240. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 249. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 252. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 253. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 260. DENMARK MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 261. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 264. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 276. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 277. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 278. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 279. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. QATAR MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 288. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 289. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. FINLAND MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 300. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 309. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 312. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 324. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 325. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 326. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 327. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 332. EGYPT MODAFINIL ORAL DRUGS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 333. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2018-2024 (USD MILLION)
TABLE 336. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY BRAND, 2025-2030 (USD MILLION)
TABLE 337. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 338. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 339. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. TURKEY MODAFINIL ORAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. TURKEY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Modafinil Oral Drugs market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Hetero Healthcare Ltd.
  • Lupin Ltd.